An animal model of humanized mice has been used by Meraz et al. to indicate that whereas carboplatin and pembrolizumab inhibit tumor growth moderately and transiently, TUSC2, a tumor suppressor gene delivered in nanovesicles, eradicates tumor growth in most animals. Here, TUSC2 is linked to neoplasm.